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INTRODUCTION
The Contingent of the International Operations appears to
be subject to various extreme factor actions, which can
cause Posttraumatic Stress Disorder (PTSD). PTSD is an
anxiety disorder that can develop after exposure to one or
more traumatic events, threatening or causing great physical
harm; it is a complex of symptoms experienced by survi-
vors of traumatic stress (Satcher, 2000). General PTSD
symptoms occur in complex psycho-physiological hypertro-
phic responses: intrusive experiences of a traumatic event,
illusions, hallucinations, persistent avoidance of stimuli as-
sociated with trauma, and general emotional numbness,
which are present for a period of at least one month. Clini-
cal diagnosis of PTSD, according to the Diagnostic and Sta-
tistical Manual of mental disorders (DSM-IV-TR), is per-
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Increased excitotoxity in response to stressors leads to oxidative stress (OS) due to accumulation
of excess reactive oxygen/nitrogen species. Neuronal membrane phospholipids are especially
susceptible to oxidative damage, which alters signal transduction mechanisms. The Contingent of
International Operations (CIO) has been subjected to various extreme stressors that could cause
Posttraumatic Stress Disorder (PTSD). Former studies suggest that heterogeneity due to gender,
race, age, nutritional condition and variable deployment factors and stressors produce challenges
in studying these processes. The research aim was to assess OS levels in the PTSD risk group in
CIO. In a prospective study, 143 participants who were Latvian CIO, regular personnel, males,
Europeans, average age of 27.4, with the same tasks during the mission, were examined two
months before and immediately after a six-month Peace Support Mission (PSM) in Afghanistan.
PCL-M questionnaire, valid Latvian language “Military” version was used for PTSD evaluation.
Glutathione peroxidase (GPx), superoxide dismutase (SOD) and lipid peroxidation intensity and
malondialdehyde (MDA) as OS indicators in blood were determined. Data were processed using
SPSS 20.0. The MDA baseline was 2.5582 µM, which after PSM increased by 24.36% (3.1815
µM). The GPx baseline was 8061.98 U/L, which after PSM decreased by 9.35% (7308.31 U/L).
The SOD baseline was 1449.20 U/gHB, which after PSM increased by 2.89% (1491.03 U/gHB).
The PTSD symptom severity (total PCL-M score) baseline was 22.90 points, which after PSM in-
creased by 14.45% (26.21 points). The PTSD Prevalence rate (PR) baseline was 0.0357, which
after PSM increased by 147.06% (0.0882). We conclude that there is positive correlation between
increase of OS, PTSD symptoms severity level, and PTSD PR in a group of patients with risk of
PTSD – CIO. PTSD PR depends on MDA intensity and OS severity. OS and increased free radi-
cal level beyond excitotoxity, is a possible causal factor for clinical manifestation of PTSD.
Key words: Posttraumatic stress disorder, oxidative stress.
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formed by means of a clinical PTSD checklist PCL-M
(military version). PCL-M includes 17 items. It is recom-
mended for use as an objective diagnostic tool for examina-
tion of patients with PTSD and PTSD risk group patients
(Anonymous, 2000; Weathers et al., 2001; Watson et al.,
2005; Pynoos et al., 2009; McDonald and Calhoun, 2010).
According to available literature data, the PTSD level be-
fore Peace Support Missions has been reported as high as
2.4–9.3% in the American Contingent of the International
Operations (Hoge et al., 2004; Riddle et al., 2007) and
2.4% in the British Contingent of the International Opera-
tions (Iversen et al., 2009). PTSD level after Peace Support
Mission is reported as 11.2% in the American Contingent of
the International Operations (Hoge et al., 2004) and
4.0–9.5% in the British Contingent of the International Op-
erations (Hotopf et al., 2006; Iversen et al., 2009).
Pathophysiology and pathogenesis of PTSD is associated
with excitotoxity. Excitotoxity is the pathological process
by which neurons are damaged due to hyperactivations of
the excitatory neurotransmitter glutamate (Li et al., 2001,
Jourdain et al., 2007). Excitotoxity-activated microglia cells
appear to become probable sources of chronic oxidative
processes leading to oxidative stress (Anwyl, 1991).
Neuronal membrane phospholipids are especially vulnera-
ble to damage; the injury leads to the receptor-mediated sig-
nal transduction and, furthermore, information processing
disorders. Studies on the effects of hyperoxidation, oxida-
tive and carbonyl stresses on cerebral suppression and its re-
lation to brain degeneration with respect of neuronal func-
tions are of great interest and importance. Indeed there are
difficulties in rating and interpreting of available literature
data, as the studies are inhomogeneous in gender, race, age,
nutritional and deployment factors — reservists or regular
personnel, and different stressful military experiences in
various Peace Support Missions.
Oxidative stress intensity was assessed considering the ma-
londialdehyde (MDA) plasma level. Unsaturated carbonyl
MDA is one of the most frequently used direct indicators of
lipid peroxidation. MDA measurement appears to be a suit-
able quantification method of the end-products of lipid
peroxidation. The production of MDA is used as a bio-
marker to measure the level of OS in an organism and is of-
ten used in oxidative stress studies (Moore and Roberts,
1998; Del Rio et al., 2005; Nie et al., 2007). MDA is a nat-
urally occurring metabolic product of polyunsaturated fat
degradation (lipid peroxidation), and has been reported to
be mutagenic and carcinogenic. Free radical damage to
lipids results in MDA reacting with DNA to form adducts to
deoxyguanosine and deoxyadenosine and releasing an inter-
mediate product of formaldehyde (Nie et al., 2007). Formal-
dehyde at low concentrations induces protein misfolding
causing a high cytotoxic aggregation. As a metabolic prod-
uct, MDA might weaken cerebral function during oxidative
stress through breaking the homeostasis between excitatory
and inhibitory neurons. Being less active than other free
radical, MDA has a rather longer half-life and, thereby, can
diffuse from the generation places to other sites, bringing
further oxidative stress. Cells are equipped with enzymatic
and nonenzymatic antioxidant systems to eliminate
ROS/RNS and maintain redox homeostasis. A major class
of enzymatic antioxidants, which catalyze the dismutation
of superoxide into oxygen and hydrogen peroxide, is known
as superoxide dismutase (SOD). Multiple isoforms of SOD
exist in different cellular compartments. SOD1 (CuZnSOD)
is the major superoxide scavenger found in the cytoplasm,
mitochondrial intermembrane space, nucleus, and lyso-
somes, whereas SOD2 (MnSOD) and SOD3 are found in
the mitochondria and extracellular matrix, respectively. In-
deed, they impart an important antioxidant defence system
and their activity increases upon oxidative stress. Some
SOD isoforms resulting from oxidative stress have been
linked with human diseases. Thus, mutations in the CuZn-
SOD can result in familial amyotrophic lateral sclerosis
(Milani et al., 2011). Further conversion of hydrogen perox-
ide occurs through the action of catalase, a heme-based en-
zyme that is normally localised in the peroxisome. Hydro-
gen peroxide also can be converted to oxygen through
coupled reactions with the conversion of reduced glu-
tathione to oxidized glutathione, catalysed by glutathione
peroxidase (GPx). The main biological role of GPx is to
protect the organism from oxidative damage. The biochemi-
cal function of GPx is to reduce lipid hydroperoxides to al-
cohols as well as to reduce free hydrogen peroxide to water
(Miyamoto et al., 2003). GPx scavenges extremely active
hydroxyl radicals without formatting toxic adverse prod-
ucts. GPx is present in a high concentration in the cells and
plays a crucial role in ensuring them in a reduced state. The
GPx role as antioxidant is particularly important for brain,
as it is very sensitive to presence of free radicals. Insuffi-
cient GPx amount and/or activity can complicate oxidative
stress. Five isoforms of selenium (Se)-dependent GPx are
found in humans. Furthermore, enzymes such as glutathione
S-transferases are known to have Se-independent peroxi-
dase activity. Nonenzymatic antioxidants (thioredoxin,
glutaredoxins, peroxiredoxins), recognised to execute thiol–
disulfide exchange reactions, also play a major role in main-
taining cellular redox balance (Trachootham et al., 2008).
Our research aim was to assess oxidative stress levels PTSD
and their correlation in the Contingent of the International
Operations.
MATERIALS AND METHODS
The prospective study was conducted in the Department of
Psychosomatic Medicine and Psychotherapy, Rîga Stradòð
University (Rîga, Latvia) in close cooperation with the Bio-
chemical Laboratory (Rîga, Latvia) and Department of In-
ternal Diseases (Rîga, Latvia) of Rîga Stradiòð University,
and Medical Care Centre of the National Armed Forces
(Rîga, Latvia). The protocol of study, the protocol of agree-
ment, and the protocol of participation corresponded to the
Helsinki declaration on principles of humanity in medicine.
The study design was approved by the Ethics Committee
of Rîga Stradiòð University, protocol No. E-9(2) of
17.12.2009. For our research we used a participant group
with the highest possible level of homogeneity to avoid dif-
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ficulties in rating and interpreting of results. In total there
were 143 male European participants, average age 27.4,
regular military personnel, participants of the Latvian Con-
tingent of the International Operations. Examination was
performed before and after the same Peace Support Mission
in Afghanistan (six months), with the same tasks during the
mission. Clinical examination and laboratory parameters as-
sessment were taken twice: two months before the mission
(BL) and immediately after the mission (PL).
Clinical examination was made according to the diagnostic
pattern DSM-IV-TR (Anonymous, 2000). The following di-
agnostic criteria were assessed:
Criterion A: Stressor. The person has been exposed to a
traumatic event in which both of the following have been
present:
1. The person has experienced, witnessed, or been con-
fronted with an event or events that involve actual or
threatened death or serious injury, or a threat to the phys-
ical integrity of oneself or others;
2. The person's response involved intense fear, helplessness,
or horror.
Criterion B: Intrusive recollection. The traumatic event is
persistently re-experienced in at least one of the following
ways:
1. Recurrent and intrusive distressing recollections of the
event, including images, thoughts, or perceptions;
2. Recurrent distressing dreams of the event;
3. Acting or feeling as if the traumatic event were recurring
(includes a sense of reliving the experience, illusions,
hallucinations, and dissociative flashback episodes, in-
cluding those that occur upon awakening or when intoxi-
cated);
4. Intense psychological distress at exposure to internal or
external cues that symbolise or resemble an aspect of the
traumatic event;
5. Physiologic reactivity upon exposure to internal or exter-
nal cues that symbolise or resemble an aspect of the trau-
matic event.
Criterion C: Avoidant/numbing. Persistent avoidance of
stimuli associated with the trauma and numbing of general
responsiveness (not present before the trauma), as indicated
by at least three of the following:
1. Efforts to avoid thoughts, feelings, or conversations asso-
ciated with the trauma;
2. Efforts to avoid activities, places, or people that arouse
recollections of the trauma;
3. Inability to recall an important aspect of the trauma;
4. Markedly diminished interest or participation in signifi-
cant activities;
5. Feeling of detachment or estrangement from others;
6. Restricted range of affect (e.g., unable to have loving
feelings);
7. Sense of foreshortened future (e.g., does not expect to
have a career, marriage, children, or a normal life span).
Criterion D: Hyper-arousal. Persistent symptoms of increas-
ing arousal (not present before the trauma), indicated by at
least two of the following:
1. Difficulty falling or staying asleep;
2. Irritability or outbursts of anger;
3. Difficulty concentrating;
4. Hyper-vigilance;
5. Exaggerated startle response;
Criterion E: Duration. Duration of the disturbance (symp-
toms in B, C, and D) is more than one month.
Criterion F: Functional significance. The disturbance causes
clinically significant distress or impairment in social, occu-
pational, or other important areas of functioning.
PCL checklist was worked out at PTSD National Centre,
USA in 1993. The PCL has a variety of purposes, including
screening individuals for PTSD, diagnosing PTSD, moni-
toring symptom change during and after treatment. There
are three versions of the PCL: PCL-C (civilian), PCL-M
(military) and PCL-S (specific). PCL-M asks about symp-
toms in response to “stressful military experiences” and is
used for active service members and veterans (Weathers et
al., 2001; Watson et al., 2005; McDonald and Calhoun,
2010). The PTSD Checklist (PCL) is a 17-item self-report
measure of the 17 DSM-IV symptoms of PTSD. Respon-
dents are asked about certain troubles during the last month;
the answers are evaluated by a 5-point scale. The valid Lat-
vian language PCL-M version was used for objective PTSD
evaluation (Voicehovskis et al., 2011). PTSD risk group In-
cidence rate (IR) was also assessed.
Laboratory assessment of oxidative stress parameters in
blood included: intensity of lipid peroxidation assessed by
malondialdehyde (MDA) concentration and activity of anti-
oxidant enzymes: glutathione peroxidase (GPx) and super-
oxide dismutase (SOD). Blood samples were taken from all
individuals in morning at 8.00 (before meal). Venous blood
was collected into a vacutainer (Venoject II BD) containing
lithium/heparin as an anticoagulant.
Activity of glutathione peroxidase 3 (GPx), Enzyme Com-
mission number (EC) 1.11.1.9, was determined in heparin-
ised whole blood by the method of Paglia and Valentine
(Paglia and Valentine, 1967) using commercial tests manu-
factured by Randox Laboratories (UK, Antrium) in a RX
Daytona analyser. GPx catalyses the oxidation of gluta-
thione (GSH) by cumene hydroperoxide. In the presence of
glutathione reductase and nicotinamide adenine dinucleo-
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tide phosphate (NADPH) the oxidised glutathione (GSSG)
is immediately converted to the reduced form with a con-
comitant oxidation of NADPH to the oxidised NADP+. The
decrease in absorbance at 340 nm is measured. In the pres-
ence of hydroperoxide, GPx catalyses oxidation of GSH to
GSSG. The latter (GSSG) undergoes NADPH-dependent
reduction to GSH catalysed by glutathione reductase. This
reaction is accompanied by NADPH oxidation to NADP+.
Thus, activity of GPx corresponds to the decrease in absorb-
ance at 340 nm induced by NADPH oxidation and one unit
of enzyme activity is defined as the enzyme content re-
quired for oxidation of 1.0 µmol of NADPH per 1 min at
340 nm and 37 °C.
Malondialdehyde (MDA) level in plasma was measured as
suggested by Gavrilov (Ãàâðèëîâ è äð., 1987): at low pH
and elevated temperature, MDA readily participates in
nucleophilic addition reaction with 2-thiobarbituric acid
(TBA), generating a red 1:2 MDA: TBA adduct. The reac-
tion products was extracted with butanol and estimated at
535 nm and 580 nm by spectrophotometry.
The determination of superoxide dismutase (SOD, EC
1.15.1.1) employed xantine and xantine oxidase to generate
superoxide radicals that react with 2-(4-iodophenyl)-3-(4-
nitrophenol)-5-phenyltetrazolium chloride to form a red for-
mazan dye (Woolliams et al., 1983). The SOD activity was
then measured by the degree of inhibitation of this reaction.
Data were processed using SPSS 20.0. Statistical signifi-
cance of mean values was evaluated by means of the
Paired-Samples T-Test and one-Sample Kolmogorov-
Smirnov test. Interrelationship between parameters was eval-
uated by the Wilcoxon correlation coefficient; differences
were considered as statistically significant at P < 0.05.
RESULTS
The main results before PSM (BL) and after (PL) the mis-
sion are represented in the Table 1.
Baseline PTSD Prevalence rate (PR) was 0.0357, which af-
ter PSM PTSD PR increased by 147.06% to 0.0882 units
(Table 2).
Baseline MDA plasma level (MDA BL, see Fig. 1) was
2.5582 µM, which after PSM MDA level (MDA PL) in-
creased by 24.36% till 3.1815 µM (Fig.2).
Baseline GPx activity (GPx BL, see Fig. 3) was 8061.98
U/L, which after PSM GPx level (GPx PL) decreased by
9.35% till 7308.31 U/L (Fig. 4).
Baseline SOD plasma activity (SOD BL, see Fig. 5) was
1449.20 U/gHB, which after PSM SOD (SOD PL) in-
creased by 2.89% till 31491.03 U/gHB (Fig. 6).
Baseline PTSD symptom severity (PCL-M score, points,
BL, see Fig. 7) total score was 22.90 PCL-M points, after
PSM PCL-M score increased by 14.45% to 26.21 points
(Fig. 8).
A negative correlation was found between MDA and GPx
(Fig. 9).
DISCUSSION
Prevalence of oxidation processes accompanied by antioxi-
dant defence system failure leads to the development of oxi-
dative stress, which is one of the universal mechanisms of
tissue damage. Enzymatic activity of antioxidant systems
(catalase, SOD, glutathione peroxidase) in the brain is sig-
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T a b l e 1
THE MAIN RESULTS BEFORE (BL) AND AFTER (PL) THE PEACE SUPPORT MISSION (PSM) (one-sample Kolmogorov-Smirnov test)
Parameters N of partici-
pants
Normal parameters 1 Most extreme differences K-S Z2 AS3
Mean SD Abs. Poz. Neg.
GPx, BL, U/L 106 8061.98 1369.116 ,061 ,061 -,048 ,623 ,832
GPx, PL, U/L 29 7308.31 1129.871 ,123 ,092 -,123 ,661 ,775
SOD, BL, U/gHB 106 1449.20 137.173 ,049 ,039 -,049 ,503 ,962
SOD, PL, U/gHB 29 1491.03 121.739 ,219 ,219 -,116 1.181 ,123
MDA, BL, µM 49 2.5582 ,63475 ,067 ,067 -,057 ,467 ,981
MDA, PL, µM 13 3.1815 ,68560 ,125 ,125 -,092 ,450 ,987
PCL, BL, points 140 22.90 6.734 ,190 ,149 -,190 2.254 ,000
PCL, PL, points 34 26.21 9.247 ,201 ,201 -,160 1.172 ,128
PTSD, BL, PR+1 140 1.04 ,186 ,540 ,540 -,424 6.393 ,000
PTSD, PL, PR+1 34 1.09 ,288 ,532 ,532 -,380 3.103 ,000
1 Test distribution is normal; calculated from data; 2 Kolmogorov-Smirnov Z; 3 asymptotic significance; SD, standard deviation; GPx, glutathione peroxidase;
SOD, superoxide dismutase; MDA, malondialdehyde; PTSD, Posttraumatic Stress Disorder; PCL-M, PTSD Checklist – Military Version
T a b l e 2
PTSD MORBIDITY BEFORE (BL) AND AFTER (PL) THE MISSION








BL gr. 143 27.36 97.90 0.0357 -
PL gr. 37 26.20 91.89 0.0882 0.1765
PTSD, Posttraumatic Stress Disorder
nificantly lower than in other tissues. Oxygen radicals (hav-
ing oxygen with an unpaired electron) are superoxide anion
and hydroxyl radical. These are extremely aggressive. Glu-
tamate is a substrate that is able to support maximal H2O2
production rates by means of [Ca
2+
] mediated excitotoxity.
Scavengers of free radicals are located in the cytoplasm or
on cell membranes; these are mainly substances with low
molecular weight: superoxide dismutase, glutathione, glu-
tathione peroxidase, catalase, ceruloplasmin, vitamin A, vi-
tamin E, vitamin C, vitamin K, flavonoids, and coumarins.
Lipid peroxidation plays a crucial role in brain injury. The
brain contains a large amount of lipids (50% in a dry mat-
ter); most of them appear to be unsaturated and become
substrates for lipid peroxidation. Phospholipids account for
over half of all lipids of nervous tissue. Fatty acid and phos-
pholipids determine structural and functional features of
cell membranes, and contribute to its penetration and den-
sity. Lipid peroxidation of any intensity results in functional
brain disorder (Esterbauer and Cheeseman, 1990; Ginsberg
and Bogousslauvsky, 1998). Moreover, it could become a




Fig. 2. Relationship of malondialdehide (MDA) before (BL) vs MDA after
the mission (PL).
Fig. 3. Glutathione peroxidase level
distribution before the mission.
cause of structural and morphological alterations, and de-
generation processes.
The PTSD patients note problems in cognition (memory, at-
tention), somatic concerns (headache), and affective deregu-
lation (impulsivity, irritability, anxiety), particularly in the
time period shortly after the traumatic event (whether psy-
chological, biomechanical, or both). A biochemical mecha-
nism associated with elevated levels of oxidative stress pa-
rameters has been proposed to explain the etiology of PTSD
(common etiology of posttraumatic stress disorder, fibromy-
algia, chronic fatigue syndrome and multiple chemical sen-
sitivity) (Pall, 2001; Pall and Satterlee, 2001; Pall, 2007;
Adibhatla and Hatcher, 2008). Alterations of glutamatergic
and NMDA receptor functions play a role in the etiology of
PTSD in humans. Some clinical studies have observed a
marked increase of cerebral neurotransmitter glutamate in
PTSD (Moghaddam et al., 1994; Chambers et al., 1999;
Cortese and Phan, 2005). Stress increases glutamate release,
which is recognised as an important mediator of excitotox-
ity. Since a prominent role of glutamate-related excitotoxity
followed by neuronal damage, glutamatergic pathways may
have an important role in stress-related hippocampal degen-
erative pathology and cognitive deficits seen in patients
with PTSD (Moghaddam et al., 1994). Brain imaging stud-
ies have revealed a marked reduction in hippocampal vol-
ume (Sapolsky, 2000; Reul and Nutt, 2008). Such morpho-
logical alterations appear to be positively correlated with
the degree of cognitive deficit noted in these patients.
PTSD-induced oxidative stress has been proposed to occur
in this disorder. Recent clinical studies confirmed the in-
volvement of neurodegenerative pathology in the PTSD
pathogenesis (Bremner, 2002). Neurochemically-mediated
damage could be conceivably related to neurohumoral dys-
regulation.
The main conclusions are:
1. MDA intensity increased during PSM; MDA intensity re-
flects the rate of lipid peroxidation and OS severity.
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Fig. 4. Glutathione peroxidase before (BL) vs after the mission (PL).
Fig. 5. Superoxide dismutase
level distribution before the
mission.
Fig. 6. Superoxide dismutase (SOD) before (BL) vs after the mission (PL).
2. GPX activity is decreased in the PTSD risk group and is
not efficient to overwork and/or control OS.
3. SOD activity is increased in the PTSD risk group but is
not efficient to overwork and/or control OS.
4. There is positive correlation between increase of oxida-
tive stress – MDA level, PTSD symptom severity level,
and PTSD Prevalence rate (PR) in the studied group of
patients with risk of PTSD (Contingent of the Interna-
tional Operations). PTSD PR depends on MDA intensity
and OS severity.
Our results suggest that the production of free radicals re-
sulteing in lipid peroxidation seemed to be related to PTSD.
The present results showed that patients with PTSD differed
from healthy controls in both antioxidant system activity
(GPx, SOD) and lipid peroxidation (MDA) level. Therefore,
we conclude that OS, increased free radical level beyond
excitotoxity, is a possible causal factor for clinical manifes-
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list – Military Version
Fig. 8. PCL-M score before (BL) vs after the mission (PL).
PCL-M, Posttraumatic Stress Disorder Checklist – Military Version
Fig. 9. Negative correlation between MDA and GPx.
MDA, malondialdehyde; GPx, glutathione peroxidase
tation of PTSD. Our results need to be confirmed by more
comprehensive and detailed further studies to support the
findings we found in PTSD.
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OKSIDATÎVÂ STRESA PARAMETRI POSTTRAUMATISKÂ STRESA SINDROMA RISKA GRUPAS PACIENTIEM
Paaugstinâts eksaitotoksicitâtes lîmenis kâ atbildes reakcija uz stresoriem lieka reaktîvâ skâbekïa/slâpekïa uzkrâðanâs rezultâtâ izraisa
oksidatîvo stresu (OS). Neironâlo membrânu fosfolipîdi ir îpaði jutîgi pret oksidatîvo bojâjumu, rezultâtâ mainot signâlu pârneses
mehânismu. Starptautisko operâciju kontingents (SOK) tiek pakïauts daþâdiem ekstremâliem stresoriem, kas varçtu izraisît posttraumatiskâ
stresa sindromu (PTSS). Pieejamie pçtîjumu dati nav viendabîgi pçc dzimuma, rases, vecuma, uztura un daþâdiem dienesta faktoriem un
stresoriem, kas apgrûtina to salîdzinâðanu. Pçtîjuma mçríis: novçrtçt OS lîmeni PTSS riska grupâ. Pçtîjumâ piedalîjâs 143 dalîbnieki —
Latvijas SOK, regulârais militârais personâls, vîrieði, eiropieði, kuru vidçjais vecums ir 27,4 gadi, ar vienâdiem uzdevumiem misijas laikâ
— tika izmeklçti divus mçneðus pirms un uzreiz pçc seðu mçneðu ilgas Miera uzturçðanas misijas (MUM) Afganistânâ. PTSS novçrtçðanai
izmantota PCL-M anketa, apstiprinâta latvieðu valodas “militârâ” versija. Asinîs noteikti OS râdîtâji: glutationa peroksidâze (GPx),
superoksîda dismutâze (SOD) un lipîdu peroksidâciju intensitâtes râdîtâjs — malondialdehîds (MDA). Dati tika apstrâdâti, izmantojot SPSS
20.0. MDA bâzes lîmenis (2,5582 µM) pçc MUM pieauga par 24,36% (3,1815 µM). GPx bâzes lîmenis (8061,98 U/L) pçc MUM
samazinâjâs par 9,35% (7308,31 U/L). SOD bâzes lîmenis (1449,20 U/gHB) pçc MUM palielinâjâs par 2,89% (1491,03 U/gHB). PTSS
simptomu smaguma (PCL-M punktu skaits) bâzes lîmenis bija 22,90 punkti, pçc MUM tas palielinâjâs par 14,45% (26,21 punkts). PTSS
izplatîbas koeficienta (IK) bâzes lîmenis bija 0,0357, pçc MUM tas pieauga par 147,06% (0,0882). Autori secina, ka pastâv pozitîva
korelâcija starp OS pieaugumu, PTSS simptomu smaguma pakâpes lîmeni un PTSS IK pacientiem PTSS riska grupâ (SOK). PTSS IK ir
atkarîgs no MDA lîmeòa un OS smaguma. Iespçjams, ka OS un eksaitotoksicitâtes rezultâtâ palielinâtais brîvo radikâïu lîmenis ir veicinoðs
faktors PTSS klîniskâs izpausmes attîstîbai.
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